Ebola Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure
Condition:   Healthy VolunteersIntervention:   Drug: rVSVdeltaG-ZEBOV GP (2X 107 pfu/mL)Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 28, 2016 Category: Research Source Type: clinical trials

Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure
Condition:   Healthy VolunteersIntervention:   Drug: rVSVdeltaG-ZEBOV GP (2X 107 pfu/mL)Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 28, 2016 Category: Research Source Type: clinical trials

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
Condition:   Ebola Virus DiseaseInterventions:   Biological: Ebola Vaccine - low dose;   Biological: Ebola Vaccine - mid dose;   Biological: Ebola Vaccine - high dose;   Biological: PlaceboSponsors:   Profectus BioSciences, Inc.;   Accelovance;   United States Department of DefenseRecruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2016 Category: Research Source Type: clinical trials